Looking to learn more about how AI is used for incidental findings? For Osteoporosis Awareness Month, we met with our Platform Partners whose AI solutions have been designed to detect signs of osteoporosis. Watch our brand new webinar where our panel of clinical leaders in the space discuss the benefits of preventive care, joined by their customers sharing their real-life experiences.
Dr. Jenna Deakin
Clinical Lead
Jenna is Blackford's Clinical Lead for Operations, a doctor by training, she has several years' experience working within Radiology. Since then, Jenna started her journey at Blackford working in the product team to build a clinically relevant portfolio of applications and now is part of the customer operations team providing clinical support throughout the customer journey.
Dr. Morteza Naghavi
Founder
Dr. Naghavi is an innovative physician scientist, entrepreneur, and life science executive with over two decades of leadership experience in academia and industry. Along with academic activities, Dr. Naghavi is also known as an entrepreneur inventor with over 20 patented inventions and multiple startup companies. He is passionate about innovations in healthcare and shifting care from late stage sick-care to early stage health-care by enabling consumers with low-cost medical technologies and actionable information powered by AI and robotics.
Dr. Robert Lufkin
Physician / Medical School Professor
Physician/medical school professor (UCLA & USC) focusing on the applied science of health, longevity, and consciousness. Helping to reimagine the conventional healthcare model with evidence-based, clinically proven lifestyle modifications and other tools. Author of over 200 peer reviewed scientific papers, 32 chapters and 13 books translated into five languages on medical imaging. Elected President of the American Society of Head and Neck Radiology and President of the Society for Magnetic Resonance Imaging and awarded the society's highest honor for his research. International reputation for excellence and has given invited lectures and keynotes in 18 countries.
Dr. Richard Ljuhar
CEO and Co-founder
Richard Ljuhar is CEO and co-founder of Image Biopsy Lab. After finishing his studies at the Technical University Vienna, Richard Ljuhar gained international experience in product development and international marketing at one of the world’s leading medical device companies based in Boston, Massachusetts. Upon returning to Austria to complete his dissertation, Richard joined Vienna-based Braincon Technologies to lead research projects in medical software applications. As part of such projects, Dr. Ljuhar co-founded ImageBiopsy Lab to use advanced image analysis algorithms for the assessment of bone microarchitecture and the overall bone morphology. ImageBiopsy Lab employs by now 25 highly skilled team members from 8 nations at its Vienna-HQ with an overall funding of more than €12M received to date.
Dr. Mischa Woisetschläger
Associate Professor of Radiology & Consultant Radiologist
Dr. Mischa Woisetschläger is an Associate Professor of Radiology and a Consultant Radiologist at the University of Linköping. He earned his medical degree and a PhD in Pathology from Albert-Ludwigs University, Freiburg, Germany, with his PhD receiving the 'magna cum laude' distinction. Dr. Woisetschläger also holds a Master of Science in Engineering and Physical Science in Medicine from Imperial College London, graduating with Distinction. He is licensed to practice as a medical radiologist in Sweden and Europe. An active member of several professional societies, he belongs to the European Society of Oncologic Imaging (ESOI), the European Society of Gastro Abdominal Radiology (ESGAR), and the Swedish Society of Gastro Abdominal Radiology (SFGAR).
Dr. Orit Wimpfheimer
Chief Medical Officer
Orit Wimpfheimer is Chief Medical Officer of Nanox, a NASDAQ traded company focusing on a both a medical device, the Nanox ARC, an tomographic imaging device using proprietary carbon nano-technology and Nanox AI which creates artificial intelligence products to facilitate population health screening from routine CT scans. Having received her MD from Albert Einstein College of Medicine, she then did her diagnostic radiology residency and fellowship at Columbia Presbyterian Medical Center. In 2022, she was a co-founder of Remote Radiology, a boutique teleradiology company based in Israel. In 2019, she joined Zebra Medical Vision as clinical director and then chief medical officer, working on multi-modality imaging AI. In 2022, Nanox bought Zebra forming one unified company.